-
Identifying Dogs to Be Screened for Canine Chronic Kidney Disease (cCKD)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of First-Line Lorlatinib for ALK-Positive Advanced NSCLC in the UK
Sep 9, 2025, 16:22 PM -
Mapping the Use of Capability Measures ICECAP-A and O in Economic Evaluations
Sep 9, 2025, 16:22 PM -
Comparison of the Environmental Impact of Subcutaneous vs. Oral Therapies
Sep 9, 2025, 16:22 PM -
Broader Economic Effects of Investment in Cancer Control in Commonwealth Countries
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Impact of Nirmatrelvir/Ritonavir in Reducing Hospitalizations Among Elderly COVID-19 Patients in Sweden
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile
Sep 9, 2025, 16:22 PM -
Superabsorbent Polymer vs. Foam Dressings for Moderate-to-Highly Exuding Chronic Leg Ulcers in Poland: Early Stage Cost-Effectiveness and Cost-Utility Analysis
Sep 9, 2025, 16:22 PM -
Mapping Writer-AI Conversations for HTA: Preliminary Analysis of 7009 Messages
Sep 9, 2025, 16:22 PM -
Diabetes Trends in France (2021-2023): A Descriptive Study Based on the THIN Database
Sep 9, 2025, 16:22 PM -
Lean Assessment Process Methodology for RMD-Health: Evaluating Clinical Need Usefulness Adoption Barriers and Early Economic Value of AI in NHS Rheumatology Referrals
Sep 9, 2025, 16:22 PM -
Economic Burden of Gaucher Disease: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Determining a Discount Rate for Pharmacoeconomic Evaluations in China: A Ramsey-Based Approach
Sep 9, 2025, 16:22 PM -
Estimating the Causal Impact of Cannabis Use on Cardiovascular Events Using Double/Debiased Machine Learning Approach
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Oral Semaglutide As a Third-Line Treatment for Patients With Type 2 Diabetes Mellitus
Sep 9, 2025, 16:22 PM -
Exploring Synergistic ADC-ICI Combinations in Breast Cancer: Clinical Insights From a Scoping Review
Sep 9, 2025, 16:22 PM -
Limited Access to Joint Scientific Consultations in 2025: Strategic Impact on Industry and Policy Directions for Sustainable EU HTA Implementation
Sep 9, 2025, 16:22 PM -
Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Network Meta-Analysis Comparing Treatments to Paclitaxel
Sep 9, 2025, 16:22 PM -
Cost per Responder Analysis of Bimekizumab, a Monoclonal IgG1 Antibody Which Selectively Inhibits Il17f in Addition to Il17a Against Il17a Inhibitors in the Treatment of Axial Spondyloarthritis in Finland
Sep 9, 2025, 16:22 PM -
Self-Reported Health Related Quality of Life (HRQoL) in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions
Sep 9, 2025, 16:22 PM